We are excited to welcome Anastasia Velentza, Ph.D., as the VP and Head of Biology at Vilya. Before joining Vilya, Anastasia led Discovery Technology at Plexium, a company focused on Targeted Protein Degradation. With over 20 years of experience in Drug Discovery, her expertise spans Discovery Biology and Molecular Pharmacology across various therapeutic areas. She has also held key positions at Novartis, Dart Neuroscience, and Ferring Pharmaceuticals. Anastasia is also the Founder of AVeNew Insights, a consulting business specializing in drug discovery. She earned her Ph.D. in Bioorganic Chemistry and a B.Sc. in Chemistry from the University of Patras, Greece. Her research has been recognized with numerous awards and is documented in over 25 publications, patents, and abstracts. Welcome to Vilya, Anastasia! #Leadership #Biotechnology #DrugDiscovery #Innovation
Congratulations Anastasia. Wishing you the best for your new role.
Congratulations Anastasia 👏🎊. You will shine wherever you go! Vilya is lucky to have you. Super excited for you!
Congratulations once again!!! So excited for you.
Anastasia, wonderful news. Congratulations and wishing you all the success in this new role
Congratulations Anastasia, best wishes for your new role!
Congratulations, Anastasia! Wishing you all the best in your new role!
Congratulations 🎉🎊
Congratulations Anastasia! So happy for you.
Congratulations! So cool to see you continue to rise up! 🔝